Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BRUN

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1995
[Cerebral abscess disclosing tetralogy of Fallot with situs inversus in adulthood]O Piot, P Guillo, F Pouillart, et al.
Genetics, Selection, Evolution : GSE|January 23, 2004
A new reciprocal translocation in a subfertile bullA Ducos, P Dumont, A Séguéla, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2015
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactamsE Weiss, J-R Zahar, P Lesprit, et al.
Physical Review Letters|May 26, 2018
Chiral Spin Texture in the Charge-Density-Wave Phase of the Correlated Metallic Pb/Si(111) MonolayerC Tresca, C Brun, T Bilgeri, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 14, 2011
Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment studyM Gazin, A Lee, L Derde, et al.
The Journal of Infectious Diseases|June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patientsMartin S King, Barry M Bernstein, Sharon L Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effectCheri Enders Klein, Yi-Lin Chiu, Walid Awni, et al.
Journal of Clinical Pharmacology|February 24, 2006
Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairmentJoanna Z Peng, Federico Pulido, Sonja J Kemmis Causemaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
HIV Clinical Trials|August 28, 2007
High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of responseDaniel Podzamczer, Martin S King, Cheri E Klein, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1995
[Cerebral abscess disclosing tetralogy of Fallot with situs inversus in adulthood]O Piot, P Guillo, F Pouillart, et al.
Genetics, Selection, Evolution : GSE|January 23, 2004
A new reciprocal translocation in a subfertile bullA Ducos, P Dumont, A Séguéla, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2015
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactamsE Weiss, J-R Zahar, P Lesprit, et al.
Physical Review Letters|May 26, 2018
Chiral Spin Texture in the Charge-Density-Wave Phase of the Correlated Metallic Pb/Si(111) MonolayerC Tresca, C Brun, T Bilgeri, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 14, 2011
Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment studyM Gazin, A Lee, L Derde, et al.
The Journal of Infectious Diseases|June 25, 2004
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patientsMartin S King, Barry M Bernstein, Sharon L Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2007
The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effectCheri Enders Klein, Yi-Lin Chiu, Walid Awni, et al.
Journal of Clinical Pharmacology|February 24, 2006
Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairmentJoanna Z Peng, Federico Pulido, Sonja J Kemmis Causemaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2008
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand, et al.
HIV Clinical Trials|August 28, 2007
High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of responseDaniel Podzamczer, Martin S King, Cheri E Klein, et al.
Pageof 30